Ipragliflozin as an add-on therapy in type 2 diabetes mellitus patients: An evidence-based pharmacoeconomics evaluation
| Autor: | Wang, Hongmei, Yao, Gaoqiong, Chen, Xi, Ouyang, Jing, Yang, Jiadan |
|---|---|
| Zdroj: | In Diabetes Research and Clinical Practice November 2019 157 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect